| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |